Phio Pharmaceuticals(PHIO) - 2024 Q3 - Quarterly Results

. Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update MARLBOROUGH, Mass., November 14, 2024 (NEWSFILE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future by using its INTASYL siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells today reported its financial results for the quarter ended September 30, 2024 and provided a bu ...